Universe Pharmaceuticals Inc Capital Reinvestment Ratio
Universe Pharmaceuticals Inc capital reinvestment ratio. Universe Pharmaceuticals Inc (UPC) has a Capital Reinvestment Ratio of 0.04x as of March 2025, meaning it reinvests 0% of its operating cash flow ($2.56 Million) in capital expenditures ($96.78K). See UPC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Universe Pharmaceuticals Inc (2018–2023)
Capital reinvestment ratio of Universe Pharmaceuticals Inc from 2018 to 2023. This chart tracks Universe Pharmaceuticals Inc's Capital Reinvestment Ratio across 4 annual periods. See financial flexibility index of Universe Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
Universe Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2018–2023)
Universe Pharmaceuticals Inc capital reinvestment ratio by year from 2018 to 2023. For the full cash flow conversion analysis, see cash flow conversion of Universe Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | $1.12 Million | $44.17K | ▲ +365.6% |
| 2020 | 0.01x | $6.12 Million | $51.80K | ▲ +29.6% |
| 2019 | 0.01x | $13.20 Million | $86.32K | ▼ -79.9% |
| 2018 | 0.03x | $4.46 Million | $145.09K | — |